Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Mutations in PIK3CA, encoding the insulin-activated phosphoinositide-3-kinase (PI3K), and loss of function mutations in PTEN, a phosphatase that degrades the phosphoinositide lipids generated by PI3K, are among the most frequent events in human cancers(1,2). Yet, pharmacological inhibition of PI3K h...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopkins, Benjamin D., Pauli, Chantal, Du, Xing, Wang, Diana G., Li, Xiang, Wu, David, Amadiume, Solomon C., Goncalves, Marcus D., Hodakoski, Cindy, Lundquist, Mark R., Bareja, Rohan, Ma, Yan, Harris, Emily M., Sboner, Andrea, Beltran, Himisha, Rubin, Mark A., Mukherjee, Siddhartha, Cantley, Lewis C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197057/
https://www.ncbi.nlm.nih.gov/pubmed/30051890
http://dx.doi.org/10.1038/s41586-018-0343-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197057/
https://www.ncbi.nlm.nih.gov/pubmed/30051890
http://dx.doi.org/10.1038/s41586-018-0343-4

Ejemplares similares